Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
Holding MGTX?
Track your performance easily
MGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.85 - $7.60
Previous Close$6.66
Volume342.78K
Average Volume (3M)274.43K
Market Cap
$515.48M
Enterprise Value$503.07M
Total Cash (Recent Filing)$99.97M
Total Debt (Recent Filing)$87.56M
Price to Earnings (P/E)―
Beta2.31
Next Earnings
Mar 12, 2025EPS Estimate
-$0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.50
Shares Outstanding77,180,000
10 Day Avg. Volume466,344
30 Day Avg. Volume274,428
Standard Deviation0.18
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)6.40
Price to Sales (P/S)67.47
Price to Cash Flow (P/CF)-7.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-85.34
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.29
Forecast
1Y Price Target
$12.00Price Target Upside70.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Meiragtx Holdings News
PremiumCompany Announcements
MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results
Ownership Overview
20.38% Insiders
3.25% Mutual Funds
2.57% Other Institutional Investors
70.55% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGTX FAQ
What was Meiragtx Holdings Plc’s price range in the past 12 months?
Meiragtx Holdings Plc lowest stock price was $3.85 and its highest was $7.60 in the past 12 months.
What is Meiragtx Holdings Plc’s market cap?
Currently, no data Available
When is Meiragtx Holdings Plc’s upcoming earnings report date?
Meiragtx Holdings Plc’s upcoming earnings report date is Mar 12, 2025 which is in 118 days.
How were Meiragtx Holdings Plc’s earnings last quarter?
Meiragtx Holdings Plc released its earnings results on Nov 07, 2024. The company reported -$0.55 earnings per share for the quarter, beating the consensus estimate of -$0.563 by $0.013.
Is Meiragtx Holdings Plc overvalued?
According to Wall Street analysts Meiragtx Holdings Plc’s price is currently Undervalued.
Does Meiragtx Holdings Plc pay dividends?
Meiragtx Holdings Plc does not currently pay dividends.
What is Meiragtx Holdings Plc’s EPS estimate?
Meiragtx Holdings Plc’s EPS estimate is -$0.57.
How many shares outstanding does Meiragtx Holdings Plc have?
Meiragtx Holdings Plc has 77,398,920 shares outstanding.
What happened to Meiragtx Holdings Plc’s price movement after its last earnings report?
Meiragtx Holdings Plc reported an EPS of -$0.55 in its last earnings report, beating expectations of -$0.563. Following the earnings report the stock price went up 4.829%.
Which hedge fund is a major shareholder of Meiragtx Holdings Plc?
Among the largest hedge funds holding Meiragtx Holdings Plc’s share is Perceptive Advisors LLC. It holds Meiragtx Holdings Plc’s shares valued at 48M.
---
Meiragtx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (70.45% Upside)
$12.00 (70.45% Upside)
Blogger Sentiment
Bullish
MGTX Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Increased
By 30.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 11.3%
Last 30 Days ▲ 11.3%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.46%
12-Months-Change
Fundamentals
Return on Equity
-91.51%
Trailing 12-Months
Asset Growth
-14.06%
Trailing 12-Months
Company Description
Meiragtx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
---
MGTX Stock 12 Month Forecast
Average Price Target
$12.00
▲(70.45% Upside)
Technical Analysis
Adaptimmune Therapeutics
―
Clearside Biomedical
―
Fate Therapeutics
―
Oncternal Therapeutics
―
Best Analysts Covering MGTX
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
-1.80%
reiterated a buy rating last month
Copying Alec Stranahan's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of -1.80% per trade.
---